Renal Biomarkers Market 2027 By Marker Type, Assay Platform, Application and Geography | The Insight Partners

Renal Biomarkers Market to 2027 - Global Analysis and Forecasts By Marker Type (Creatinine, Blood Urea Nitrogen (BUN, Cystatin C, Neutrophil Gelatinase-Associated Lipocalin (NGAL), Others); Assay Platform (Enzyme Linked Immunosorbent Assay (ELISA), Enzymatic Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Others); Application (Diagnosis and Disease Progression Monitoring, Research) and Geography

Report Code: TIPRE00004914 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
The biomarkers are measurable indicators of presence and severity of any disease that indicates the state of disease for which the therapeutic intervention is planned in accordance. The biomarkers are majorly used to diagnose the presence of any existing as well as developing disease. The renal biomarker checks the appropriate working of kidneys, and developing disease related to kidney by measuring blood and urine level. Biomarkers are needed to prevent the higher rate of kidney disorders and for prediagnosis.

MARKET DYNAMICS
The major factors which are expected to provide market growth are increase incidences of kidney disease, rise in geriatric population, the use of biomarkers in clinical and preclinical trials, loss of kidney function, increase in prevalence of chronic diseases, aging population and others. Additionally, increase in investment in research and development are anticipated to provide opportunities in market growth.

MARKET SCOPE
The "Global Renal Biomarkers Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of renal biomarkers market with detailed market segmentation by marker type, assay platform type, application, and geography. The global renal biomarkers market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading renal biomarkers market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global renal biomarkers market is segmented on the basis of marker type, assay platform type, and application. Based on marker type, the market is segmented as creatinine, blood urea nitrogen (BUN), cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), and others. Based on assay platform type the market is segmented as enzyme linked immunosorbent assay (ELISA), enzymatic assay particle-enhanced turbidimetric immunoassay (PETIA), and others. On the basis of application, the renal biomarkers market is segmented into diagnosis and disease progression monitoring, and research.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global renal biomarkers market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The renal biomarkers market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting renal biomarkers market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the renal biomarkers market in these regions.

MARKET PLAYERS
The reports cover key developments in the renal biomarkers market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from renal biomarkers market are anticipated to lucrative growth opportunities in the future with the rising demand for renal biomarkers in the global market. Below mentioned is the list of few companies engaged in the renal biomarkers market.

The report also includes the profiles of key renal biomarkers market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott
  • F. Hoffmann-La Roche AG
  • Beckman Coulter Inc.
  • Siemens Healthcare Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • Astute Medical Inc.
  • RenalSense Ltd
  • bioMérieux SA
  • Randox Laboratories Ltd.
  • BIOPORTO A/S,
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Renal Biomarkers Market - By Marker Type
1.3.2 Renal Biomarkers Market - By Assay Platform
1.3.3 Renal Biomarkers Market - By Application
1.3.4 Renal Biomarkers Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RENAL BIOMARKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RENAL BIOMARKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RENAL BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. RENAL BIOMARKERS - GLOBAL MARKET OVERVIEW
6.2. RENAL BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RENAL BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - MARKER TYPE
7.1. OVERVIEW
7.2. MARKER TYPE MARKET FORECASTS AND ANALYSIS
7.3. CREATININE
7.3.1. Overview
7.3.2. Creatinine Market Forecast and Analysis
7.4. BLOOD UREA NITROGEN (BUN
7.4.1. Overview
7.4.2. Blood Urea Nitrogen (BUN Market Forecast and Analysis
7.5. CYSTATIN C
7.5.1. Overview
7.5.2. Cystatin C Market Forecast and Analysis
7.6. NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL)
7.6.1. Overview
7.6.2. Neutrophil Gelatinase-Associated Lipocalin (NGAL) Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. RENAL BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - ASSAY PLATFORM
8.1. OVERVIEW
8.2. ASSAY PLATFORM MARKET FORECASTS AND ANALYSIS
8.3. ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
8.3.1. Overview
8.3.2. Enzyme Linked Immunosorbent Assay (ELISA) Market Forecast and Analysis
8.4. ENZYMATIC ASSAY
8.4.1. Overview
8.4.2. Enzymatic Assay Market Forecast and Analysis
8.5. PARTICLE-ENHANCED TURBIDIMETRIC IMMUNOASSAY (PETIA)
8.5.1. Overview
8.5.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. RENAL BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSIS AND DISEASE PROGRESSION MONITORING
9.3.1. Overview
9.3.2. Diagnosis and Disease Progression Monitoring Market Forecast and Analysis
9.4. RESEARCH
9.4.1. Overview
9.4.2. Research Market Forecast and Analysis
10. RENAL BIOMARKERS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Renal Biomarkers Market Overview
10.1.2 North America Renal Biomarkers Market Forecasts and Analysis
10.1.3 North America Renal Biomarkers Market Forecasts and Analysis - By Marker Type
10.1.4 North America Renal Biomarkers Market Forecasts and Analysis - By Assay Platform
10.1.5 North America Renal Biomarkers Market Forecasts and Analysis - By Application
10.1.6 North America Renal Biomarkers Market Forecasts and Analysis - By Countries
10.1.6.1 United States Renal Biomarkers Market
10.1.6.1.1 United States Renal Biomarkers Market by Marker Type
10.1.6.1.2 United States Renal Biomarkers Market by Assay Platform
10.1.6.1.3 United States Renal Biomarkers Market by Application
10.1.6.2 Canada Renal Biomarkers Market
10.1.6.2.1 Canada Renal Biomarkers Market by Marker Type
10.1.6.2.2 Canada Renal Biomarkers Market by Assay Platform
10.1.6.2.3 Canada Renal Biomarkers Market by Application
10.1.6.3 Mexico Renal Biomarkers Market
10.1.6.3.1 Mexico Renal Biomarkers Market by Marker Type
10.1.6.3.2 Mexico Renal Biomarkers Market by Assay Platform
10.1.6.3.3 Mexico Renal Biomarkers Market by Application
10.2. EUROPE
10.2.1 Europe Renal Biomarkers Market Overview
10.2.2 Europe Renal Biomarkers Market Forecasts and Analysis
10.2.3 Europe Renal Biomarkers Market Forecasts and Analysis - By Marker Type
10.2.4 Europe Renal Biomarkers Market Forecasts and Analysis - By Assay Platform
10.2.5 Europe Renal Biomarkers Market Forecasts and Analysis - By Application
10.2.6 Europe Renal Biomarkers Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Renal Biomarkers Market
10.2.6.1.1 Germany Renal Biomarkers Market by Marker Type
10.2.6.1.2 Germany Renal Biomarkers Market by Assay Platform
10.2.6.1.3 Germany Renal Biomarkers Market by Application
10.2.6.2 France Renal Biomarkers Market
10.2.6.2.1 France Renal Biomarkers Market by Marker Type
10.2.6.2.2 France Renal Biomarkers Market by Assay Platform
10.2.6.2.3 France Renal Biomarkers Market by Application
10.2.6.3 Italy Renal Biomarkers Market
10.2.6.3.1 Italy Renal Biomarkers Market by Marker Type
10.2.6.3.2 Italy Renal Biomarkers Market by Assay Platform
10.2.6.3.3 Italy Renal Biomarkers Market by Application
10.2.6.4 Spain Renal Biomarkers Market
10.2.6.4.1 Spain Renal Biomarkers Market by Marker Type
10.2.6.4.2 Spain Renal Biomarkers Market by Assay Platform
10.2.6.4.3 Spain Renal Biomarkers Market by Application
10.2.6.5 United Kingdom Renal Biomarkers Market
10.2.6.5.1 United Kingdom Renal Biomarkers Market by Marker Type
10.2.6.5.2 United Kingdom Renal Biomarkers Market by Assay Platform
10.2.6.5.3 United Kingdom Renal Biomarkers Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Renal Biomarkers Market Overview
10.3.2 Asia-Pacific Renal Biomarkers Market Forecasts and Analysis
10.3.3 Asia-Pacific Renal Biomarkers Market Forecasts and Analysis - By Marker Type
10.3.4 Asia-Pacific Renal Biomarkers Market Forecasts and Analysis - By Assay Platform
10.3.5 Asia-Pacific Renal Biomarkers Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Renal Biomarkers Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Renal Biomarkers Market
10.3.6.1.1 Australia Renal Biomarkers Market by Marker Type
10.3.6.1.2 Australia Renal Biomarkers Market by Assay Platform
10.3.6.1.3 Australia Renal Biomarkers Market by Application
10.3.6.2 China Renal Biomarkers Market
10.3.6.2.1 China Renal Biomarkers Market by Marker Type
10.3.6.2.2 China Renal Biomarkers Market by Assay Platform
10.3.6.2.3 China Renal Biomarkers Market by Application
10.3.6.3 India Renal Biomarkers Market
10.3.6.3.1 India Renal Biomarkers Market by Marker Type
10.3.6.3.2 India Renal Biomarkers Market by Assay Platform
10.3.6.3.3 India Renal Biomarkers Market by Application
10.3.6.4 Japan Renal Biomarkers Market
10.3.6.4.1 Japan Renal Biomarkers Market by Marker Type
10.3.6.4.2 Japan Renal Biomarkers Market by Assay Platform
10.3.6.4.3 Japan Renal Biomarkers Market by Application
10.3.6.5 South Korea Renal Biomarkers Market
10.3.6.5.1 South Korea Renal Biomarkers Market by Marker Type
10.3.6.5.2 South Korea Renal Biomarkers Market by Assay Platform
10.3.6.5.3 South Korea Renal Biomarkers Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Renal Biomarkers Market Overview
10.4.2 Middle East and Africa Renal Biomarkers Market Forecasts and Analysis
10.4.3 Middle East and Africa Renal Biomarkers Market Forecasts and Analysis - By Marker Type
10.4.4 Middle East and Africa Renal Biomarkers Market Forecasts and Analysis - By Assay Platform
10.4.5 Middle East and Africa Renal Biomarkers Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Renal Biomarkers Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Renal Biomarkers Market
10.4.6.1.1 South Africa Renal Biomarkers Market by Marker Type
10.4.6.1.2 South Africa Renal Biomarkers Market by Assay Platform
10.4.6.1.3 South Africa Renal Biomarkers Market by Application
10.4.6.2 Saudi Arabia Renal Biomarkers Market
10.4.6.2.1 Saudi Arabia Renal Biomarkers Market by Marker Type
10.4.6.2.2 Saudi Arabia Renal Biomarkers Market by Assay Platform
10.4.6.2.3 Saudi Arabia Renal Biomarkers Market by Application
10.4.6.3 U.A.E Renal Biomarkers Market
10.4.6.3.1 U.A.E Renal Biomarkers Market by Marker Type
10.4.6.3.2 U.A.E Renal Biomarkers Market by Assay Platform
10.4.6.3.3 U.A.E Renal Biomarkers Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Renal Biomarkers Market Overview
10.5.2 South and Central America Renal Biomarkers Market Forecasts and Analysis
10.5.3 South and Central America Renal Biomarkers Market Forecasts and Analysis - By Marker Type
10.5.4 South and Central America Renal Biomarkers Market Forecasts and Analysis - By Assay Platform
10.5.5 South and Central America Renal Biomarkers Market Forecasts and Analysis - By Application
10.5.6 South and Central America Renal Biomarkers Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Renal Biomarkers Market
10.5.6.1.1 Brazil Renal Biomarkers Market by Marker Type
10.5.6.1.2 Brazil Renal Biomarkers Market by Assay Platform
10.5.6.1.3 Brazil Renal Biomarkers Market by Application
10.5.6.2 Argentina Renal Biomarkers Market
10.5.6.2.1 Argentina Renal Biomarkers Market by Marker Type
10.5.6.2.2 Argentina Renal Biomarkers Market by Assay Platform
10.5.6.2.3 Argentina Renal Biomarkers Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. RENAL BIOMARKERS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BECKMAN COULTER INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SIEMENS HEALTHCARE DIAGNOSTICS INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. THERMO FISHER SCIENTIFIC INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTUTE MEDICAL INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. RENALSENSE LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOMéRIEUX SA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RANDOX LABORATORIES LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BIOPORTO A/S,
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. F. Hoffmann-La Roche AG
3. Beckman Coulter Inc.
4. Siemens Healthcare Diagnostics Inc.
5. Thermo Fisher Scientific Inc.
6. Astute Medical Inc.
7. RenalSense Ltd
8. bioMérieux SA
9. Randox Laboratories Ltd.
10. BIOPORTO A/S,